Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06925646 · ClinicalTrials.gov registry record
Hand Perfusion and Pulse Oximetry Performance
A clinical trial, sponsored by Mayo Clinic.
- Not yet
- Registry status
- 20
- Enrollment target
NCT06925646: Clinical Trial study, sponsored by Mayo Clinic.
NCT06925646 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06925646 has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to compare oxygen saturation measurement readings from manufactured pulse oximetry devices to the oxygen saturation measurements of arterial blood samples drawn at the same time of measurements.
Primary Outcome
Arterial oxygen saturation will be obtained via a blood sample at the end of each stage of the breath down protocols and is reported as a percentage.
Interventions
- PROCEDURE Finger hyperperfusion via adenosine
- PROCEDURE Finger hypoperfusion via by norepinephrine
- PROCEDURE Baseline hypoxic test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2028-10-01 |
What is known before NCT06925646 opens enrollment
NCT06925646 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Finger hyperperfusion via adenosine is the first listed.
NCT06925646 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06925646 about?
NCT06925646 is a clinical study titled "Hand Perfusion and Pulse Oximetry Performance". The purpose of this study is to compare oxygen saturation measurement readings from manufactured pulse oximetry devices to the oxygen saturation measurements of arterial blood samples drawn at the same time of measurements.
What is the current status of trial NCT06925646?
This trial is currently not yet recruiting. The enrollment target is 20 participants. The study started on 2026-09-01. Estimated completion is 2028-10-01.
What interventions are being tested in trial NCT06925646?
The interventions under investigation include: Finger hyperperfusion via adenosine (PROCEDURE), Finger hypoperfusion via by norepinephrine (PROCEDURE), Baseline hypoxic test (PROCEDURE).
Who is sponsoring clinical trial NCT06925646?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI